5-Ethyl-2-methylpiperidine → 1-{[5-(2-Chlorophenyl)isoxazol-4-yl]carbonyl}-5-ethyl-2-methylpiperidine
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[O:12][N:11]=[CH:10][C:9]=1[C:13]([OH:15])=O.[CH2:16]([CH:18]1[CH2:23][NH:22][CH:21]([CH3:24])[CH2:20][CH2:19]1)[CH3:17]>>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[O:12][N:11]=[CH:10][C:9]=1[C:13]([N:22]1[CH2:23][CH:18]([CH2:16][CH3:17])[CH2:19][CH2:20][CH:21]1[CH3:24])=[O:15]Participants
3
Procedure
The title compound was prepared from 5-(2-chlorophenyl)isoxazole-4-carboxylic acid (11.2 mg, 0.050 mmol) and 5-ethyl-2-methylpiperidine (7.6 mg, 0.060 mmol) as described in synthetic method C and thereafter purified by preparative HPLC method B to give a solid (2.8 mg). Calcd for C18H21ClN2O2: 332.1292, found 332.1293.
Workup
- custompurified by preparative HPLC method B
Sources & evidence
- ORD record
- ord-84d0e09911444e619d73e2709d7a725a
- Source dataset
- uspto-grants-2010_02
- Patent number
- US07666888B2
Reaction notes
Loading…